Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.12 AUD -4% Market Closed
Market Cap: 35.1m AUD
Have any thoughts about
Next Science Ltd?
Write Note

Next Science Ltd
Investor Relations

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

Show more
Loading
NXS
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Harry Thomas Hall
MD, CEO & Director
No Bio Available
Dr. Matthew Franco Myntti
Founder & CTO
No Bio Available
Marc Zimmerman
Chief Financial Officer
No Bio Available
Mr. Jon Swanson
Chief Operating Officer
No Bio Available
Mr. Robert Bell
Senior Vice President of North American Sales
No Bio Available
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD
Company Secretary
No Bio Available

Contacts

Address
NEW SOUTH WALES
Chatswood
Tower B, The Zenith L 19, 821 Pacific Highway
Contacts
+61286075124.0
www.nextscience.com
sparklesyt

See Also

Summary
NXS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NXS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NXS stock valuation using valuation multiples.
Wall Street Estimates
NXS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NXS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 229,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.